Dandong First Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials

Phase

• Phase 32 trials

Status

• Not yet recruiting2 trials

Lead sponsor

• Beijing Tiantan Hospital1 trial
• First Hospital of China Medical University1 trial

Running trials

• Not yet recruiting

  Ongericimab Injection Reducing Recurrence of Ischemic Stroke

  NCT07242599· Phase 3· Beijing Tiantan Hospital· Source

  Contact: Lishu Wan

• Not yet recruiting

  Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

  NCT07476898· Phase 3· First Hospital of China Medical University· Source

  Contact: Lishu Wan

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke2 recruiting